Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares Outstanding
Ratios

Merit Medical Systems (MMSI) R&D In Process (2016 - 2023)

Merit Medical Systems (MMSI) has disclosed R&D In Process for 9 consecutive years, with $1.5 million as the latest value for Q2 2023.

  • Quarterly R&D In Process fell 76.77% to $1.5 million in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2023, down 76.77% year-over-year, with the annual reading at $1.5 million for FY2023, 76.77% down from the prior year.
  • R&D In Process hit $1.5 million in Q2 2023 for Merit Medical Systems, down from $6.7 million in the prior quarter.
  • In the past five years, R&D In Process ranged from a high of $6.7 million in Q2 2022 to a low of $25000.0 in Q1 2019.
  • Historically, R&D In Process has averaged $2.2 million across 3 years, with a median of $1.0 million in 2019.
  • Biggest five-year swings in R&D In Process: skyrocketed 63.4% in 2019 and later tumbled 76.77% in 2023.
  • Year by year, R&D In Process stood at $500000.0 in 2019, then surged by 1234.2% to $6.7 million in 2022, then crashed by 76.77% to $1.5 million in 2023.
  • Business Quant data shows R&D In Process for MMSI at $1.5 million in Q2 2023, $6.7 million in Q2 2022, and $500000.0 in Q2 2019.